REVAMP Study (REmodeling the Left Ventricle withAtrial Modulated Pacing)
Basic eligibility criteria:
Please contact the study coordinator for additional eligibility information.
Key Inclusion Criteria:
-Subject has had a market released dual chamber Medtronic Pacemaker with a Sleep function for at least 6 months
- Subject is stable on current medications
-Subject has dyspnea with exertion
Primary disease category: Heart/Cardiovascular
Sponsor: Medtronic, Inc.
Projected enrollment dates: September 2017 to September 2019
Official study title: REVAMP Study (REmodeling the Left Ventricle withAtrial Modulated Pacing)